María Pilar
Garrido López
Profesor/a Asociado/a en CC. de la Salud
University of Manchester
Mánchester, Reino UnidoPublicaciones en colaboración con investigadores/as de University of Manchester (6)
2020
-
Choice of second-line systemic therapy in stage IV small cell lung cancer (SCLC) – A decision-making analysis amongst European lung cancer experts
Lung Cancer, Vol. 146, pp. 6-11
-
Treatment of brain metastases in small cell lung cancer: Decision-making amongst a multidisciplinary panel of European experts
Radiotherapy and Oncology, Vol. 149, pp. 84-88
2019
-
Consolidative thoracic radiotherapy in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts
Radiotherapy and Oncology, Vol. 135, pp. 74-77
-
Erratum to “Consolidative thoracic radiotherapy in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts” [Radiother. Oncol. 135 (2019) 74–77](S0167814019300775)(10.1016/j.radonc.2019.02.010)
Radiotherapy and Oncology
-
Prophylactic cranial irradiation in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts
Radiotherapy and Oncology, Vol. 133, pp. 163-166
2017
-
Selumetinib plus docetaxel compared with docetaxel alone and progression-free survival in patients with KRAS-mutant advanced non-small cell lung cancer: The SELECT-1 randomized clinical trial
JAMA - Journal of the American Medical Association, Vol. 317, Núm. 18, pp. 1844-1853